Silicon Laboratories Inc. — Form 10-Q Summary
Reporting period: Second quarter and six months of fiscal 2023, ended July 1, 2023; comparative periods ended July 2, 2022. The filing period differs from the request metadata indicating 2022 Q2.
Business context and financial performance
Silicon Labs designs mixed-signal integrated circuits and wireless solutions for Internet of Things markets. It operates as a fabless semiconductor company, relying on third parties, largely in Asia, for wafer fabrication, assembly and testing. Unless otherwise noted, amounts below are in millions of U.S. dollars.
- Q2 revenue: $244.9, down 6.9% year over year. Industrial & Commercial grew 14.7% to $165.3; Home & Life declined 33.1% to $79.6.
- Q2 profitability: Gross profit was $143.8, with a 58.7% gross margin versus 62.3% a year earlier. Operating income was $17.2 versus $31.4; net income was $11.0 versus $22.1. Diluted EPS was $0.33 versus $0.60.
- First-half results: Revenue was $491.7, down 1.1%; gross margin was 60.5% versus 64.3%; operating income was $36.7 versus $65.0; net income was $24.9 versus $45.0. Diluted EPS was $0.75 versus $1.18.
- Cash flow: Operating activities used $15.5 in the first half, versus $83.4 generated in the prior-year period. Investing activities provided $416.1, primarily reflecting sales and maturities of investments; financing activities used $665.7, including debt repayment and share repurchases.
- Liquidity and debt: Cash, cash equivalents and short-term investments totaled $505.9 at quarter-end, down from $1,191.9 at year-end 2022. The company had $80.0 outstanding under its $400.0 revolving facility and no convertible notes outstanding. It reported compliance with credit-facility covenants.
- Working capital: Accounts receivable were $98.3; DSO was 36 days, versus 25 at year-end. Inventory was $145.5; DOI was 130 days, versus 90 at year-end. Management attributed inventory growth to building stock to reduce supply-disruption risk and meet expected demand.
Material changes versus the prior comparable period
- Home & Life weakness outweighed Industrial & Commercial growth. Management said average selling prices increased while unit volumes decreased in the quarter and first half.
- Gross margin declined, which management attributed primarily to product mix and variations in product prices and costs. Research and development expense rose, while selling, general and administrative expense fell in Q2; operating expenses overall were lower year over year in the quarter.
- The effective tax rate rose to 53.0% in Q2 from 33.2%, and to 44.6% for the first half from 33.5%, primarily because lower forecasted pretax income magnified the impact of permanent tax items.
- In June, the company settled or redeemed its 2025 convertible notes, paying $535.0 in cash and issuing 0.9 million shares. It also borrowed $80.0 under the revolving facility. Q2 repurchases totaled 1.3 million shares for $183.5.
Outlook, risks and unusual items
- Q3 fiscal 2023 outlook: Revenue of $190–$210; gross margin of 59%; operating expenses of approximately $120; diluted EPS of $(0.08) to $0.20. Management expected R&D and SG&A expenses to decrease in absolute dollars in Q3.
- Management said current cash, investments, credit availability and expected operating cash generation should meet short- and long-term capital requirements, including at least the next 12 months.
- Key risks include semiconductor-industry downturn and customer inventory levels, inflation and interest rates, supply-chain capacity and dependence on Asian suppliers, and geopolitical tensions involving China and Taiwan. The company also cited distributor and customer concentration: two distributors each exceeded 10% of first-half revenue, and distributors represented 80% of revenue.
- The company is appealing a Norwegian tax assessment of approximately $13.1 related to 2013; it believes its position is more likely than not to be sustained but says an unfavorable outcome could materially affect its financial statements. Routine litigation was not expected to have a material adverse effect.
- As a subsequent event, the company estimated a $3.3 net tax benefit from temporary IRS foreign tax credit relief, most of which it expected to recognize in Q3 2023. In July, the board increased the share-repurchase authorization from $500 to $600.
Most important facts for investors to verify
- Whether the Q3 revenue and EPS outlook is achieved, particularly given the sharp Home & Life decline and reported lower unit volumes.
- Whether margin pressure and elevated inventory and receivables improve, and whether operating cash flow returns to positive territory.
- How the $80.0 revolving-facility borrowing and cash balance evolve following the convertible-note settlement and continued repurchases.
- Developments in the Norwegian tax appeal, the expected timing and recognition of the $3.3 tax benefit, and any changes in the cited supply-chain or geopolitical risks.